162 related articles for article (PubMed ID: 34692992)
1. Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions.
Riggan KA; Stewart EA; Balls-Berry JE; Venable S; Allyse MA
J Patient Exp; 2021; 8():23743735211049655. PubMed ID: 34692992
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.
Orellana M; Riggan KA; DSouza K; Stewart EA; Venable S; Balls-Berry JE; Allyse MA
J Racial Ethn Health Disparities; 2022 Aug; 9(4):1184-1191. PubMed ID: 34013445
[TBL] [Abstract][Full Text] [Related]
5. "In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.
Orellana M; DSouza KN; Yap JQ; Sriganeshan A; Jones ME; Johnson C; Allyse M; Venable S; Stewart EA; Enders F; Balls-Berry JE
BMC Womens Health; 2024 Apr; 24(1):233. PubMed ID: 38610011
[TBL] [Abstract][Full Text] [Related]
6. Black Women's Psychosocial Experiences with Seeking Surgical Treatment for Uterine Fibroids: Implications for Clinical Practice.
VanNoy BN; Bowleg L; Marfori C; Moawad G; Zota AR
Womens Health Issues; 2021; 31(3):263-270. PubMed ID: 33610438
[TBL] [Abstract][Full Text] [Related]
7. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
8. "I Wasn't Presented With Options": Perspectives of Black Veterans Receiving Care for Uterine Fibroids in the Veterans Health Administration.
Carey C; Silvestrini M; Callegari LS; Katon JG; Bossick AS; Doll KM; Christy A; Washington DL; Owens S
Womens Health Issues; 2023; 33(6):652-660. PubMed ID: 37689493
[TBL] [Abstract][Full Text] [Related]
9. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
10. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
12. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
13. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
14. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Management of Giant Uterine Fibroid: A Case Report.
Rout M; Dave A; Bakshi SS
Cureus; 2023 Nov; 15(11):e48169. PubMed ID: 38046766
[TBL] [Abstract][Full Text] [Related]
16. Patient Experiences with a Multidisciplinary Fibroid Program.
Musselman K; Shin JH; Lamparello NA; Ahsan MD; Havryliuk Y; Schiffman M; Fenster T; Pepin K
J Minim Invasive Gynecol; 2024 Apr; ():. PubMed ID: 38677410
[TBL] [Abstract][Full Text] [Related]
17. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.
Segars JH; Parrott EC; Nagel JD; Guo XC; Gao X; Birnbaum LS; Pinn VW; Dixon D
Hum Reprod Update; 2014; 20(3):309-33. PubMed ID: 24401287
[TBL] [Abstract][Full Text] [Related]
18. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Jun; 89(3):305-18. PubMed ID: 16001461
[TBL] [Abstract][Full Text] [Related]
19. Women seeking second opinion for symptomatic uterine leiomyoma: role of comprehensive fibroid center.
Tan N; McClure TD; Tarnay C; Johnson MT; Lu DS; Raman SS
J Ther Ultrasound; 2014; 2():3. PubMed ID: 25512867
[TBL] [Abstract][Full Text] [Related]
20. Treatment of symptomatic fibroid disease using uterine fibroid embolisation: An Australian perspective.
Clements W; Ang WC; Law M; Goh GS
Aust N Z J Obstet Gynaecol; 2020 Jun; 60(3):324-329. PubMed ID: 31956995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
